EP 3844268 A1 20210707 - NOVEL RECOMBINANT NEWCASTLE DISEASE VIRUS
Title (en)
NOVEL RECOMBINANT NEWCASTLE DISEASE VIRUS
Title (de)
NEUARTIGES REKOMBINANTES MORBUS-NEWCASTLE-VIRUS
Title (fr)
NOUVEAU VIRUS RECOMBINANT DE LA MALADIE DE NEWCASTLE
Publication
Application
Priority
- EP 18192074 A 20180831
- EP 2019073113 W 20190829
Abstract (en)
[origin: WO2020043835A1] The present invention relates to a new recombinant paramyxovirus which can be used as a vector for gene expression in a eukaryotic cell or for treating a cancerous disease in a human.
IPC 8 full level
C12N 7/00 (2006.01)
CPC (source: EP)
C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 2760/18121 (2013.01); C12N 2760/18122 (2013.01)
Citation (search report)
See references of WO 2020043835A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
DOCDB simple family (application)
EP 2019073113 W 20190829; EP 19762750 A 20190829